Technical Analysis for BWAY - Brainsway Ltd.

Grade Last Price % Change Price Change
C 8.76 1.51% 0.13
BWAY closed up 1.51 percent on Thursday, May 13, 2021, on 1.73 times normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: May 20
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Flat Up
Historical BWAY trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Fell Below 20 DMA Bearish 1.51%
Fell Below 50 DMA Bearish 1.51%
Older End-of-Day Signals for BWAY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 7 hours ago
Rose Above Upper Bollinger Band about 7 hours ago
2x Volume Pace about 7 hours ago
1.5x Volume Pace about 7 hours ago
Up 5% about 7 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which Brainsway received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). Brainsway is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders, including smoking cessation and post-traumatic stress disorder, and is planning trials for opioid addiction, fatigue in multiple sclerosis (MS) and post-stroke rehabilitation.

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Neuroscience Mental Health Opioid FDA Multiple Sclerosis Stroke Psychiatry Major Depressive Disorder Depressive Disorder Smoking Neurophysiology Neurotechnology Neuromodulation Smoking Cessation Treatment Of Major Depressive Disorder Addiction Fatigue Obsessive Compulsive Disorder Neuropsychology Neuromodulation Products Post Traumatic Stress Disorder Treatment Of Depression Transcranial Magnetic Stimulation

Is BWAY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 11.0
52 Week Low 5.52
Average Volume 70,195
200-Day Moving Average 7.38
50-Day Moving Average 8.80
20-Day Moving Average 8.63
10-Day Moving Average 8.65
Average True Range 0.48
ADX 25.97
+DI 35.94
-DI 12.90
Chandelier Exit (Long, 3 ATRs ) 8.49
Chandelier Exit (Short, 3 ATRs ) 9.55
Upper Bollinger Band 9.14
Lower Bollinger Band 8.13
Percent B (%b) 0.63
BandWidth 11.63
MACD Line -0.04
MACD Signal Line -0.07
MACD Histogram 0.0277
Fundamentals Value
Market Cap 97.46 Million
Num Shares 11.1 Million
EPS -1.03
Price-to-Earnings (P/E) Ratio -8.52
Price-to-Sales 3.27
Price-to-Book 3.46
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.29
Resistance 3 (R3) 10.40 10.00 10.04
Resistance 2 (R2) 10.00 9.61 9.95 9.95
Resistance 1 (R1) 9.38 9.37 9.69 9.27 9.86
Pivot Point 8.98 8.98 9.14 8.93 8.98
Support 1 (S1) 8.36 8.59 8.67 8.25 7.66
Support 2 (S2) 7.96 8.35 7.91 7.57
Support 3 (S3) 7.34 7.96 7.49
Support 4 (S4) 7.23